345 Park Avenue South

Cure by Deerfield Launches Middle East Health Accelerator in Qatar Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Become a Member

Learn About Our Events

Thumbnail Events Mega Menu Highlight - X Factor Image

Magenta

Events

Accelerating Advances in Health

Green

About

Contact us

Paul Oestreicher, PhD, is an accomplished public affairs professional. He is a trusted advisor and mentor known for strategic communications, thought leadership development, crisis and reputation management, talent and team development, and third-party relationship building. He has held leadership positions at organizations including Roche, Sanofi, Edelman, and Medidata. Oestreicher was also an Adjunct Professor at New York University’s MS Program in Public Relations & Corporate Communication, where he taught Strategic Communication, Research Process & Methodology, and Communication Ethics, Law & Regulation and was honored with NYU’s Award for Teaching Excellence. Oestreicher writes frequently about healthcare, leadership, trust, and change, and is the author of *Camelot, Inc.: Leadership and Management Insights from King Arthur and the Round Table*. He earned a bachelor’s degree in biology from the University of Rochester, a PhD in nutritional sciences from Rutgers University, and completed a post-doctoral fellowship in pharmacology while with Wyeth Laboratories (Pfizer).

Contributing Writer

Sunbird Bio's platform aims to address a $20 billion global neurology diagnostics market to test for Alzheimer’s, Parkinson’s, ALS and more. 

How Sunbird Bio is Changing Brain Disease Diagnoses  

First Patients Join Study of Wandercraft Home-Use Exoskeleton

Sunbird Bio’s CEO shares how focus, timing, and smart scaling can turn biotech volatility into long-term value.

4 Steps to Building a Biotech Company That Lasts image

4 Steps to Building a Biotech Company That Lasts

BioCurie is harnessing AI to optimize the production of cell, gene, and RNA therapies, significantly transforming the economic landscape of advanced therapeutics.

BioCurie Team Photo Image

BioCurie Leads AI-Powered Biomanufacturing Revolution

Distinguished physician-scientist and biotech CEO, William Pao, MD, PhD, highlights the frequently overlooked scientists whose collaborative, multi-generational efforts shape modern drug development.

The Hidden Power Driving Drug Discovery Innovation

Deepecho’s AI-driven ultrasound tools poised to transform healthcare in underserved regions globally.

Deepecho’s AI-driven Ultrasound Advances Maternal Healthcare

Wandercraft CEO Matthieu Masselin shares how AI and robotics are reshaping mobility solutions, improving quality of life, and addressing global challenges.

Revolutionizing Movement: Robotic Mobility Solutions

Shalabh Gupta, MD, CEO and founder of Unicycive Therapeutics, is on a mission to revolutionize kidney disease care by changing drug formulation to address the overwhelming number of daily pills patients must take.

How can Nanoparticles Transform Kidney Disease Care

Public Health Thank You Day, spearheaded by Research!America and leading public health organizations, recognizes those who safeguard our communities' health. 

Public Health thank you day

5 Things to Know about Public Health Thank You Day 

Award-winning journalist and cancer survivor creates Cancer Vaccine Coalition

thumbnail_krysten_dalhgren_thames

Kristen Dahlgren’s Journey to Cancer Vaccine Advocate

Evommune, Inc., a clinical-stage biotech and Cure Collaboration Residency company, secured $115 million in Series C financing, underscoring its pioneering approach to developing novel therapies for chronic inflammatory diseases.

Evommune $115M Series C Funding Fuels Innovation in Chronic Inflammation

To Greg Simon, former leader of President Biden's Cancer Moonshot, saving lives hinges less on new technologies and more on the effective access to existing ones.

thumbnail_telemedicine_tablet_pc

Simon Calls for Healthcare Reform Focused on Accessibility

Rick Weissenstein, Managing Director at TD Cowen, shared his insights on how the outcome of the US presidential election will shape healthcare policy and innovation landscape.

2024 U.S. Election: How Harris or Trump Could Shape Healthcare Policy, Pricing and Innovation

Evommune, led by CEO Luis Peña, is on a mission of tackle one of the world’s leading root cause of deaths: chronic inflammation, which is linked to more than 100 autoimmune diseases.

thumb_luis_pena_evommune

How Evommune is Redefining Treatments for Chronic Inflammatory and Autoimmune Diseases

Infectious disease experts critically differ in awareness, concern and reaction to the surge of mosquito-borne diseases from those on the front line, both primary care physicians and the public, finds Cure's Mosquito-Borne Diseases Benchmark Report 2024.

Uninformed, Unconcerned: Ignoring the Global Surge of Mosquito-Borne Diseases at Our Peril

Advocating health policy, economics and technology for US  hospitals is a role Charles N. "Chip" Kahn, III, MPH, readily takes on as President and CEO of the Federation of American Hospitals.

thumbnail_laser_mri_cat_scan

Chip Kahn Advocates for American Healthcare and Hospitals

Suja Mathew, MD, EVP and Chief Clinical Officer of Atlantic Health System, is helping steer its vision to move beyond traditional hospital walls and focus on whole-patient care.

Suja Mathew’s Vision for Atlantic Health System Thumbnail

Transforming Healthcare with Whole-Patient Care Approach

Increased Eastern equine encephalitis (EEE) cases in 2024, likely influenced by warmer weather, has led to public health warnings and actions.

Encephalitis vaccines thumbnail 1200x675

Eastern Equine Encephalitis: Tackling a Rare but Severe Disease

Lexeo Therapeutics is developing pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease.

Lexeo Therapeutics: Revolutionizing Genetic Medicine for Cardiovascular and Neurodegenerative Diseases 

As the flu season approaches and COVID-19 remains a significant concern, understanding the optimal timing for vaccinations is crucial.

vaccinations timing thumbnail 1200x675

It’s That Time Again: The Importance of Timing for Flu and COVID-19 Vaccinations 

General David H. Petraeus discussed the challenges to healthcare posed by global conflicts at the C3 Healthcare Summit, aka "Davos of Healthcare."


Healthcare Delivery and Innovation in a World of Conflict 

Leveraging her background ​as a food scientist, ​Laura Katz, MA, ​founded​ and helms Helaina, a company using its​ proprietary  platform to recreate the ​bioactive proteins found in​ human colostrum and​ milk​ to improve health for people of all ages​. 

Events Thumbnail Tuesday Talks Laura Katz 

Helaina: Transforming Nutrition with Bioactive Proteins  

Evommune founder Luis Peña expertise spans a spectrum of life science companies. He co-founded Dermira, was Senior Vice President of Portfolio Planning and Management at Stiefel, and held key roles at Connetics, Theravance and Genentech.

Business discussion

The Science of Leadership: 5 Insights from Evommune CEO Luis Peña

Before he became CEO of Lexeo Therapeutics, R. Nolan Townsend, MBA, worked across Pfizer, in Finance, Corporate Strategy, Operations and Marketing, and Rare Disease in North America, Asia, Africa/Middle East and Europe. 


Female CEO

Global Perspective: Top 3 Leadership Lessons from Lexeo CEO Nolan Townsend

image women health menopause

Menopause Treatment: Delay and Disappointment

Biotech Insilico Medicine aims to transform drug discovery and development using generative AI. that discovers novel targets, generates new molecules, and predicts clinical trial success.


Patient Engagement Is the Secret to Smarter Research—Here’s How to Nail It

Meet the 15 Startups Joining Cure’s Middle East Health Accelerator

Your Home in NYC

Cure Events

Learn About Our Events

Accelerating Advances in Health

Paul Oestreicher

26 Articles by Paul Oestreicher